Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9561 studies found for:    "Growth Substances"
Show Display Options
Download search resultsDownload the search results for:
"Growth Substances" (9561 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Conditions: Metastatic Hepatocellular Carcinoma;   Advanced Liver Cancer
Interventions: Drug: Ascorbic Acid + Sorafenib;   Drug: Sorafenib alone
2 Completed Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
3 Terminated Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Condition: Stage IV Colorectal Cancer
Intervention: Drug: Vitamin C
4 Terminated Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Pancreatic Neoplasms;   Advanced Disease;   Sunitinib
Intervention: Drug: Sutent
5 Terminated Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
Conditions: Hepatocellular Carcinoma;   Fibrolamellar Hepatocellular Carcinoma
Intervention: Drug: Sutent
6 Completed Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)
Conditions: Respiratory Tract Infections;   Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil);   Dietary Supplement: Miglyol oil
7 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
8 Completed Patellar Tendon Regeneration With Platelet-rich Plasma
Condition: Knee Instability
Interventions: Procedure: Platelet-rich plasma;   Procedure: Control group
9 Terminated Growth Hormone and Heart Failure
Condition: Heart Failure, Congestive
10 Completed A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
Conditions: HIV Infections;   Peripheral Nervous System Disease
Intervention: Drug: Nerve Growth Factor, Recombinant Human
11 Recruiting Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Condition: Malignant Pleural Effusion
Intervention: Drug: Bevacizumab
12 Not yet recruiting A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial
Condition: Iron Deficiency, Anaemia in Children
Interventions: Dietary Supplement: IHAT;   Dietary Supplement: Ferrous Sulphate;   Other: Placebo
13 Not yet recruiting Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
Condition: Iron Deficiency Anemia
Interventions: Drug: Iron isomaltoside;   Drug: Iron sucrose
14 Not yet recruiting Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
Condition: Iron Deficiency Anaemia
Interventions: Drug: Iron isomaltoside;   Drug: Iron Sucrose
15 Recruiting BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
Condition: Psoriasis
Interventions: Drug: BAY1003803;   Drug: Clobetasol propionate;   Drug: Betamethasone/calcipotriene
16 Not yet recruiting Phase 1b Evaluating the Safety and Efficacy of OPomD in Relapsed or Refractory Multiple Myeloma
Condition: Relapsed or Refractory Multiple Myeloma
Interventions: Drug: Od formulation 1;   Drug: Od formulation 2;   Drug: OPomD formulation 1;   Drug: OPomD formulation 2
17 Completed Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: IDP-123 Lotion;   Drug: Tazorac Cream;   Drug: Vehicle Lotion;   Drug: Vehicle Cream
18 Recruiting High Dose Carfilzomib for Newly Diagnosed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Dexamethasone
19 Not yet recruiting Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise
Condition: G6PD Deficiency
Interventions: Dietary Supplement: Alpha-lipoic acid;   Other: Placebo
20 Not yet recruiting Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention: Drug: Vitamin D

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years